Company / Depreciation & Amortization
ALX ONCOLOGY HOLDINGS INC Depreciation & Amortization History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$342.0K
FY2022
5-year range
$342.0K / $431.0K
FY2020-FY2022
Trend
-20.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $431,000 to $342,000 over the past 2 years.
Based on SEC 10-K filings.
$342,000 in FY2022.
Improved from $431,000 to $342,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, depreciation & amortization decreased 20.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $342.0K | -20.3% |
| FY2021 | $429.0K | -0.5% |
| FY2020 | $431.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026